Literature DB >> 19875740

Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials.

Raul G Nogueira1, David S Liebeskind, Gene Sung, Gary Duckwiler, Wade S Smith.   

Abstract

BACKGROUND AND
PURPOSE: The Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI trials evaluated the safety and efficacy of thrombectomy in the treatment of intracranial arterial occlusions within 8 hours of symptom onset. We sought to determine the predictors of clinical and angiographic outcomes in these patients.
METHODS: The trial cohorts were combined in a data set of 305 patients. Twenty-eight baseline variables were included in univariate and multivariate analyses to define the independent predictors of good outcomes (modified Rankin Scale score </=2), mortality, and successful revascularization (Thrombolysis In Myocardial Ischemia 2 to 3 flow).
RESULTS: In the univariate analysis, final revascularization, baseline National Institutes of Health Stroke Scale, age, and systolic blood pressure were associated with both good outcomes and mortality at 90 days (P<0.0018 for all). In the multivariate analysis, final revascularization (OR, 20.4; 95% CI, 7.7 to 53.9; P<0.0001), baseline National Institutes of Health Stroke Scale (OR, 0.86; 95% CI, 0.81 to 0.92; P<0.0001), and age (OR, 0.96; 95% CI, 0.95 to 0.98; P=0.0004) were independent predictors of good outcome. Final revascularization (OR, 0.28; 95% CI, 0.16 to 0.50; P<0.0001), baseline National Institutes of Health Stroke Scale score (odds ratio, 1.09; 95% CI, 1.04 to 1.14; P=0.0001), age (OR, 1.05; 95% CI, 1.03 to 1.07; P<0.0001), and internal carotid artery occlusion (OR, 2.17; 95% CI, 1.22 to 3.86; P=0.0084) were the strongest predictors of mortality. Systolic blood pressure (<150 versus >or=150 mm Hg; OR, 0.42; 95% CI, 0.26 to 0.70; P=0.0007) and M2 occlusion (OR, 3.86; 95% CI, 1.28 to 11.67; P=0.0168) were independent predictors of revascularization.
CONCLUSIONS: Final recanalization status represents the strongest predictor of clinical outcomes in patients undergoing thrombectomy. The ability to remove the clot is negatively influenced by systolic blood pressure on presentation perhaps because of the hydraulic forces imposed by higher blood pressures. Although internal carotid artery occlusions are associated with increased mortality, they do not appear to influence the chances of good outcomes. This finding supports the inclusion of internal carotid artery occlusions in future efficacy trials.

Entities:  

Mesh:

Year:  2009        PMID: 19875740     DOI: 10.1161/STROKEAHA.109.561431

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  78 in total

1.  Hyperdensity on non-contrast CT immediately after intra-arterial revascularization.

Authors:  Joon-Tae Kim; Suk-Hee Heo; Bang-Hoon Cho; Seong-Min Choi; Seung-Han Lee; Man-Seok Park; Woong Yoon; Ki-Hyun Cho
Journal:  J Neurol       Date:  2011-10-21       Impact factor: 4.849

2.  Early blood pressure management for endovascular therapy in acute ischemic stroke: A review of the literature.

Authors:  Bin Han; Xuan Sun; Xu Tong; Baixue Jia; Dapeng Mo; Xiaoqing Li; Gang Luo; Zhongrong Miao
Journal:  Interv Neuroradiol       Date:  2020-06-11       Impact factor: 1.610

3.  Endovascular Thrombectomy in Acute Ischemic Stroke: Outcome in Referred Versus Directly Admitted Patients.

Authors:  Philipp Bücke; Marta Aguilar Pérez; Elisabeth Schmid; Christian H Nolte; Hansjörg Bäzner; Hans Henkes
Journal:  Clin Neuroradiol       Date:  2017-01-31       Impact factor: 3.649

Review 4.  Endovascular therapy in hyperacute ischaemic stroke: history and current status.

Authors:  Alex M Mortimer; Marcus D Bradley; Shelley A Renowden
Journal:  Interv Neuroradiol       Date:  2013-12-18       Impact factor: 1.610

5.  Efficacy and safety of an early Solitaire stent retrieval technique for acute ischemic stroke.

Authors:  Byung Hoon Lee; Yoon Joon Hwang; Keun-Sik Hong; Yong-Jin Cho
Journal:  Jpn J Radiol       Date:  2013-06-14       Impact factor: 2.374

6.  Influence of a combined CT/C-arm system on periprocedural workflow and procedure times in mechanical thrombectomy.

Authors:  Johannes Pfaff; Silvia Schönenberger; Christian Herweh; Mirko Pham; Simon Nagel; Peter Arthur Ringleb; Sabine Heiland; Martin Bendszus; Markus Alfred Möhlenbruch
Journal:  Eur Radiol       Date:  2017-02-17       Impact factor: 5.315

Review 7.  Revascularization grading in endovascular acute ischemic stroke therapy.

Authors:  O O Zaidat; M A Lazzaro; D S Liebeskind; N Janjua; L Wechsler; R G Nogueira; R C Edgell; J S Kalia; A Badruddin; J English; D Yavagal; J F Kirmani; A V Alexandrov; P Khatri
Journal:  Neurology       Date:  2012-09-25       Impact factor: 9.910

Review 8.  Developing practice recommendations for endovascular revascularization for acute ischemic stroke.

Authors:  Marc A Lazzaro; Roberta L Novakovic; Andrei V Alexandrov; Ziad Darkhabani; Randall C Edgell; Joey English; Donald Frei; Dara G Jamieson; Vallabh Janardhan; Nazli Janjua; Rashid M Janjua; Irene Katzan; Pooja Khatri; Jawad F Kirmani; David S Liebeskind; Italo Linfante; Thanh N Nguyen; Jeffrey L Saver; Lori Shutter; Andrew Xavier; Dileep Yavagal; Osama O Zaidat
Journal:  Neurology       Date:  2012-09-25       Impact factor: 9.910

9.  A model of rat embolic cerebral infarction with a quantifiable, autologous arterial blood clot.

Authors:  Norihito Shimamura; Naoya Matsuda; Kiyohide Kakuta; Akiko Narita; Hiroki Ohkuma
Journal:  Transl Stroke Res       Date:  2013-05-25       Impact factor: 6.829

10.  Impact of Merci device fracture on clinical outcome of acute ischemic stroke after mechanical thrombectomy.

Authors:  Zhong-Song Shi; Gary R Duckwiler; Yince Loh; David S Liebeskind; Nestor R Gonzalez; Satoshi Tateshima; Reza Jahan; Jeffrey L Saver; Fernando Viñuela
Journal:  CNS Neurosci Ther       Date:  2012-08-20       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.